Ian Dunn to Adenoma
This is a "connection" page, showing publications Ian Dunn has written about Adenoma.
Connection Strength
3.799
-
An institutional experience in applying quality improvement measures to pituitary surgery: clinical and resource implications. Neurosurg Focus. 2023 Dec; 55(6):E10.
Score: 0.827
-
Genomic Alterations in Sporadic Pituitary Tumors. Curr Neurol Neurosci Rep. 2018 02 02; 18(1):4.
Score: 0.552
-
Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors. Endocrinology. 2017 07 01; 158(7):2284-2291.
Score: 0.530
-
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors. Oncotarget. 2016 Nov 22; 7(47):76565-76576.
Score: 0.508
-
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Management of Patients With Nonfunctioning Pituitary Adenomas: Executive Summary. Neurosurgery. 2016 Oct; 79(4):521-3.
Score: 0.503
-
Demonstration of Infectious Transgression Through the Skull Base Occurring 9 Years After Pituitary Adenoma Resection. World Neurosurg. 2018 Nov; 119:215-219.
Score: 0.143
-
Functional Gonadotroph Adenomas: Case Series and Report of Literature. Neurosurgery. 2016 Dec; 79(6):823-831.
Score: 0.127
-
Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas. J Clin Neurosci. 2016 Dec; 34:246-251.
Score: 0.126
-
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary Adenomas. Neurosurgery. 2016 Oct; 79(4):E541-3.
Score: 0.126
-
Time Course of Symptomatic Recovery After Endoscopic Transsphenoidal Surgery for Pituitary Adenoma Apoplexy in the Modern Era. World Neurosurg. 2016 Dec; 96:434-439.
Score: 0.126
-
The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: early experience in the Advanced Multimodality Image Guided Operating suite. Neurosurg Focus. 2016 Mar; 40(3):E18.
Score: 0.121
-
Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease. J Clin Endocrinol Metab. 2021 01 01; 106(1):e94-e102.
Score: 0.042
-
Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease. Clin Cancer Res. 2020 03 01; 26(5):1141-1151.
Score: 0.039
-
Incidence, risk factors and management of severe post-transsphenoidal epistaxis. J Clin Neurosci. 2015 Jan; 22(1):116-22.
Score: 0.027